Company Info

Revenue

$354.5

Visit Website

Emcure Pharmaceuticals

CDMO

Tagline

Success Through Innovation

Overview

Emcure Pharmaceuticals Ltd. is a pharmaceutical company engaged in developing, manufacturing and marketing a broad range of pharmaceutical products. The company was incorporated on April 16, 1981. Its vision is to manufacture innovative, high-tech products, which satisfy the needs of customers. The company has acquired International Pharmaceutical Generics (IPG) Ltd. in 2016. Its research is focused on developing a portfolio of differentiated products across several platforms including chiral molecules, biosimilars and novel drug delivery systems. The company is developing novel drug delivery systems based on the liposomal and nanotechnology platforms.

Company Services

Services/CapabilitiesCDMO

+ Biomanufacturing

cGMP Microbial Manufacturing
Vaccine Development & Manufacturing

+ Development Services

Analytical Development & Validation
Preformulation/Formulation
Process Development & Validation
Scale Up/Tech Transfer
Stability Testing

+ Drug Product Manufacturing

Cytotoxic / High Potency Compounds (OEL < 1µg/m3)
Lyophilized Products Manufacturing
Sterile Bags Manufacturing

+ Drug Substance Manufacturing

Advanced Intermediates
Controlled Substances
Cytotoxic / High Potency Compounds (OEL < 1µg/m3)

+ Packaging

Prefilled Syringes/Cartridges/Pen Devices